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Abstract
Background: Exosomes play a major role in cell-to-cell communication, targeting cells to transfer exosomal molecules including
proteins, mRNAs, and microRNAs (miRNAs) by an endocytosis-like pathway. miRNAs are small noncoding RNA molecules on average
22 nucleotides in length that regulate numerous biological processes including cancer pathogenesis and mediate gene down-
regulation by targeting mRNAs to induce RNA degradation and/or interfering with translation. Recent reports imply that miRNAs can
be stably detected incirculating plasmaandserum since miRNAsare packaged byexosomestobeprotected from RNA degradation.
Thus, profiling exosomal miRNAs are in need to clarify intercellular signaling and discover a novel disease marker as well.
Methodology/Principal Findings: Exosomes were isolated from cultured cancer cell lines and their quality was validated by
analyses of transmission electron microscopy and western blotting. One of the cell lines tested, a metastatic gastric cancer
cell line, AZ-P7a, showed the highest RNA yield in the released exosomes and distinctive shape in morphology. In addition,
RNAs were isolated from cells and culture media, and profiles of these three miRNA fractions were obtained using
microarray analysis. By comparing signal intensities of microarray data and the following validation using RT-PCR analysis,
we found that let-7 miRNA family was abundant in both the intracellular and extracellular fractions from AZ-P7a cells, while
low metastatic AZ-521, the parental cell line of AZ-P7a, as well as other cancer cell lines showed no such propensity.
Conclusions/Significance: The enrichment of let-7 miRNA family in the extracellular fractions, particularly, in the exosomes
from AZ-P7a cells may reflect their oncogenic characteristics including tumorigenesis and metastasis. Since let-7 miRNAs
generally play a tumor-suppressive role as targeting oncogenes such as RAS and HMGA2, our results suggest that AZ-P7a
cells release let-7 miRNAs via exosomes into the extracellular environment to maintain their oncogenesis.
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Introduction
Cells secrete different types of small membrane vesicles.
Exosomes are one of the vesicles with 30–100 nm diameter and
physicochemically distinct from other secreted vesicles [1]. Inside
exosomes, cellular gene products including proteins, mRNAs, and
microRNAs (miRNAs) are packaged and these molecules can be
transferred to recipient cells to deliver their molecular signaling
such as oncogenesis [2–4] and immune response [1,5]. Exosomes
are released by many types of cells [6] which include tumor cells,
epithelial cells, and hematopoietic cells such as reticulocytes,
cytotoxic T lymphocytes, Epstein-Barr virus-transformed B cells,
mastocytes, dendritic cells, and platelets. Secreted exosomes have
been isolated and characterized in vitro from cultured cell lines [7]
along with in vivo in body fluids [7] including blood [8], urine [9],
saliva [10], amniotic fluid [11], and malignant pleural effusions
[12]. Since observed in many proliferating cell types, it is
conceivable to exacerbate tumor cells, as evidenced by their
increased presence in plasma and pleural effusions of patients with
cancer [8,12]. This increased presence in non-invasive body fluids
of cancer patients has accelerated to profile molecular components
in the exosomes for discovering clinically useful tumor markers
and biomarkers [3,7,13].
miRNAs are a class of noncoding small RNAs that are involved
in post-translational regulation of gene expression by inhibiting
both stability and translation of mRNAs [14]. Recent evidence has
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13247shown that miRNA mutations or misexpression correlate with
various human cancers and indicate that some miRNAs can
function as oncogenes or tumor suppressors [15,16]. To analyze
RNAs, it is always to consider their stability from degradation by
RNase. Recent findings indicate that endogenous plasma miRNAs
in blood samples are stably detectable in a form that is resistant to
RNase activity [17], evidenced by identification of miRNAs in
body fluids such as blood [17–24], urine [25], and saliva [10,26].
Cultured cancer cells have been used to search for tumor
markers. In particular, identifying proteins and peptides secreted
into the culture media has developed by proteomics-based
approach [27,28]. As for molecular signature in the exosomes,
proteomics as well as transcriptomics analyses have been
performed to reveal tumorigenesis and identify tumor marker
candidates [2–4,7,29]. Here, to identify miRNA related to
tumorigenesis and metastasis, we performed extensive miRNA
analysis in three cellular fractions including cells, exosomes, and
medium from cultured cells. Ranking data of these intracellular
and extracellular miRNAs obtained by microarray analysis, we
found that let-7 miRNA family is rich in all the fractions from AZ-
P7a cells, a metastatic gastric cancer cell line, which produces
homogeneous and condensed morphology, and high recovery rate
of exosomal miRNAs. These findings were distinct from other cell
lines including lung cancer cell lines (SBC-3, NCI-H69, and
DMS53), colorectal cancer cell lines (SW480 and SW620), and
AZ-521, the parental cell line of AZ-P7a. Considering that let-7
miRNA family functions mainly as tumor suppressor genes [30] to
target oncogenes such as RAS and high mobility group A2
(HMGA2) [31], we propose that AZ-P7a cells selectively secrete let-
7 miRNAs into the extracellular environment via exosomes to
maintain their tumorigenic and metastatic propensities.
Results
Isolation of exosomes from various cancer cell lines
Exosomes are produced from inner cells to the extracellular
environment via an exocytosis-like pathway [1]. In addition to body
fluids such as serum and plasma from peripheral blood [7,8],
exosomes are found in the medium of cultured cells [7], facilitating
identification of exosomal molecules including proteins, mRNAs,
and miRNAs for the aim for their clinical use. Profiling such
exosomal molecules produced in cultured cancer cells have led to
discover a novel candidate marker and antigen for cancer
diagnostics and immunotherapy [7]. In this study, for the purpose
of profiling exosomal miRNAs, we first isolated exosomes from
culture media of 46 cancer cell lines with various tissue types, which
include 8 for stomach, 16 for lung, 5 for colon, 9 for pancreas, 3 for
prostate, and 5 for breast. After cells were grown for 48 h, exosomes
were collected with a combination of successive centrifugation and
molecular weight cut-off membranes as described in Materials and
Methods. Their purity of exosomal fractions was assessed by
analyses of transmission electron microscopy and western blotting.
Transmission electron microscopy showed round-shaped vesicular
membrane structures approximately within the size of 100 nm in
diameter. Among three cell lines, SBC-3, AZ-521, and AZ-P7a, it is
of interest that the morphology from AZ-P7a cells was more
homogeneous and condensed than other cells (Figure 1A). Im-
munoelectron microscopy showed that the extracellular particles
isolated from the culture medium of AZ-P7a cells had immunore-
activity with an antibody against CD63, one of the exosomal
membrane proteins, on the capsular membranes (Figure 1B). The
presence of known exosomal proteins including CD29/b1-integrin,
Aip1/Alix and tumor susceptibility gene 101 (Tsg101) was
confirmed by western blot analysis, while a protein localized to
endoplasmic reticulum, Bip/Grp78, was undetectable (Figure 1C).
This result indicates that the contamination of material derived
from other cellular compartments in the exosomal fractions was
minimal. The yield of exosomal proteins from AZ-P7a cells was 10
times higher than that from AZ-521 cells; ,2.5 mg proteins were
obtained from 1610
8 AZ-P7a cells.
Enrichment of exosomal RNAs derived from AZ-P7a cells
After isolation, exosomal total RNAs were isolated from 46
cultured cell lines. Interestingly, the RNA yields from AZ-P7a cells
were much greater than those from other cells (Figure 2A). The
distribution in length showed the presence of large amounts of small
RNAs in exosomes (center panel, Figure 2B). It should be noted that
there is a significant difference in total exosomes and the exosomal
miRNA levels between patients with lung adenocarcinoma and
controls [8]. AZ-P7a cell line was established by repeated
inoculation of the parental AZ-521 cells in mice, resulted in high
peritoneal-metastaticpotential[32,33].Thus,the highyieldsofboth
RNA and protein along with the morphological characteristics in
AZ-P7a cells may be attributed to their high tumorigenic and
metastatic propensities. Since miRNAs have been detected in cell-
free body fluids [17–20], we also performed direct isolation of total
RNAs from culture medium without procedure for isolating
exosomes. The amounts of total RNAs from culture media were
generally greater than those from exosomes (Figure 2A). RNA
distribution in length showed that miRNA fractions were detected
in the range from 10 to 40 nucleotide length in RNAs prepared
from culture medium (rightpanel) aswell asexosomes (center panel)
from AZ-P7a cells (Figure 2B). According to the manufacture’s
protocol for Bioanalyzer, peaks with longer than 40 nucleotide
length contain other small RNAs including tRNAs at 70,90, 5S
ribosomal RNA at 100, and 5.8S ribosomal RNA at 150, as
observed in the intracellular fraction (left panel). These results
suggest that miRNAs may exist in the culture medium outside the
exosomal fraction although RNAs are believed to be protected from
RNases as being packaged in exosomes. Particularly, compared to
adherent cells, the increment of RNA yields was remarkably greater
infloating cells(NCI-H69 and Lu-135) or cellswithmixpopulations
of floating and adherent cells (Colo205), which may be reflected by
contamination of RNAs shed from lysed cells that have been
continuously left in culture media.
miRNA profiling by microarray analysis
miRNA profiles in the intracellular and extracellular fractions
were determined by microarray analysis for seven cancer cell lines
including AZ-521, AZ-P7a, SBC-3, NCI-H69, DMS53, SW480,
and SW620. Samples from culture media as well as exosomes
provided hybridization signals (Figure 3), indicating the existence of
miRNAs in these samples. Up to the present, analyzing microarray
data for miRNA among samples, no clear methods have been made
for normalization of signal intensity since it is difficult to find an
appropriate internal standard material [34]. Thus, miRNA
microarray data have been in general analyzed without normali-
zation, assuming that the total amounts of input RNAs are constant
among samples [34,35]. In this study, after averaging miRNA
microarray data between two replicates, we ranked miRNAs
according to their signal intensities. We found that let-7 miRNA
family such as let-7a, let-7b, let-7c, let-7d, let-7e, let-7f, let-7g, and
let-7i were detected with relatively high signals throughout most of
the intracellular fractions from the seven cell lines (Table 1,
Figure 3). However, no or little signal intensities for the let-7
miRNAs were detected in the extracellular fractions except both
extracellular fractions from AZ-P7a cells and culture medium
fraction from NCI-H69 cells (Table 1, Figure 3). Particularly, in
Let-7 MicroRNA Secretion
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miRNAs were detected although the rank of let-7g was lower than
other seven let-7 miRNAs. Based on the distinct patterns of let-7
miRNA levels among the three cellular fractions, we divided the
seven cell lines into three groups (Figure 3) as follows; (1) AZ-P7a,
cells that let-7 miRNAs were found in all the three fractions, (2) AZ-
521alongwith SBC-3,DMS53,SW480,and SW620,cellsthatlet-7
miRNAs were generally found in only intracellular fractions, (3)
NCI-H69, cells that let-7 miRNAs were found in the intracellular
fractions as well as in the culture medium to some extent.
RT-PCR analyses of intracellular and extracellular let-7
miRNA family
We then performed quantitative RT-PCR for the eight let-7
miRNA family to validate the microarray data. let-7 miRNAs were
readily detected in the intracellular and extracellular fractions from
AZ-P7a cells (Figure 4A) and AZ-521 cells (Figure 4B). The levels of
let-7 miRNAs per input RNAs were generally higher in the
extracellular fractions from AZ-P7a cells than from AZ-521 cells.
For normalizing the levels of target miRNAs obtained by RT-PCR,
U6 snRNA has been generally used as an internal control. We
observed the presence of U6 snRNA in all the three fractions from
AZ-P7a cells and AZ-521 cells (Figure 4C) and then compared the
levels of let-7 miRNAs between the corresponding fractions from
these two cell lines. After normalization, the levels of let-7 miRNAs
including let-7a, let-7b, let-7c, let-7d, let-7e, and let-7i in both the
fractions of exosomes and culture media from AZ-521 cells were
lowered as compared with those from AZ-P7a cells. On the
contrary, there was no large difference in the levels of the
intracellular let-7 miRNAs. We next compared the level of
β
μ
Figure 1. Characterization of exosomes. A. Morphological characterization of exosomes derived from AZ-P7a, AZ-521, and SBC-3 cells by
transmission electron microscopy. B. Immunoelectron micrographs of AZ-P7a exosomes labeled with immunogold anti-CD63. Exosomes with black
colloidal gold particles on the capsular membranes were observed as positive CD 63 staining under the transmission electron microscope
(arrowheads). C. Molecular characterization of exosomes derived from AZ-P7a, AZ-521, and SBC-3 cells by western blot analysis. Protein extracts
(10 mg) prepared from cells (C) or exosomes (Ex) were assessed using antibodies against exosomal protein markers (CD29/b1-integrin, Aip1/Alix, and
Tsg101) and an endoplasmic reticulum marker (Bip/Grp78).
doi:10.1371/journal.pone.0013247.g001
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lines including SBC-3, NCI-H69, DMS53, SW480, and SW620,
and found that the let-7a level only from SW620 cells was relatively
close (0.7 times) to the level from AZ-P7a cells (Figure 4E). It should
be noticed that the intracellular level of let-7a from SW620 cells was
approximately 3.5 times more abundant than that from AZ-P7a
cells. Based on these results, we assumed localization of let-7a in the
fractions of cells and exosomes (Figure 5), and conducted further
analysis. Normalized by the U6 levels, we calculated relative levels
of let-7a packaged in exosomes per the levels of cellular let-7a
(Figure 4F). As a result, the amount of exosomal let-7a was much
greater in AZ-P7a cells than other six cells, suggesting that AZ-P7a
cells were selectively and actively secreted let-7 miRNA family into
the extracellular environment via exosomes.
Discussion
In the present study, we revealed that let-7 miRNA family was
secreted into the extracellular environment via exosomal transport,
which was specific to a metastatic gastric cancer cell line, AZ-P7a.
let-7 miRNA family in human consists of 10 sequences from 13
precursors [30]. In general, let-7 miRNAs act as a tumor suppressor
by targeting oncogenes such as RAS and HMGA2 and let-7 miRNAs
are downregulated in many cancers from solid organs [31]. AZ-P7a
cells possess a metastatic ability with peritoneal dissemination in
nude mice [32,33]. Thus, we propose that the exosomal release of
let-7 miRNAs into the extracellular environment results in decrease
of anti-tumorigenic effect within the cells, which lead to maintain
their oncogenesis and invasiveness. On the other hand, let-7
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Figure 2. Total RNAs in exosomes and culture media from various cancer cell lines. A. Amounts of total RNAs recovered from exosomes
(lower panel) and culture media (upper panel). The amount of total RNAs per cell was shown. B. Distribution in length of RNA. Isolated total RNAs
from the exosomes and culture medium of AZ-P7a cells were detected using Bioanalyzer. The result of cellular total RNAs was shown for comparison.
doi:10.1371/journal.pone.0013247.g002
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of expression by hypomethylation at the let-7 locus [36] or targeting
caspase-3 mRNA [37]. In this case, the exosomal release of let-7
miRNAs may cause transformation in target cells by transferring
their oncogenic properties.
In patients with lung cancer, the total levels of exosomes and
their miRNAs increase compared to controls [8]. It has been
demonstrated that tumor exosomes induce immune escape
mechanism in cancers by spontaneous T cell apoptosis [38–40].
In this study, we have shown homogeneous morphology and
enrichment of RNAs in exosomes from metastatic AZ-P7a cells.
This may be reflected by their tumorigenicity.
miRNAs are very stable in blood plasma and serum since
protected from RNases [17]. Thus, it makes miRNA levels tested
for clinical diagnosis as tumor markers and biomarkers. How does
it happen? Chin et al. have suggested two hypotheses for the
source of miRNAs on circulating blood samples; it may be due to a
result of tumor cell death and lyses or release by tumor cells into
Figure 3. miRNA profiling in the intra- and extra-cellular fractions from AZ-P7a, AZ-521, NCI-H69, SBC-3, DMS53, SW480 and
SW620 cells. miRNA profiles in cells (C), exosomes (Ex), and culture media (CM) were obtained by miRNA microarray analysis. Y axis represents log2
of hybridization signals, shown by bars and filled boxes. The arrows on the left side from the bunch of signals represent signals corresponding to let-7
miRNA family including let-7a (red), let-7b (yellow), let-7c (light green), let-7d (dark green), let-7e (sky blue), let-7f (blue), let-7g (navy blue), and let-7i
(purple).
doi:10.1371/journal.pone.0013247.g003
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contrary to adherent cells, we observed that the amounts of total
RNAs in culture media were relatively higher than in exosomes for
cells with floating property such as NCI-H69, Lu-135, and
Colo205. This increment probably resulted in the contamination
of RNAs from dead cells in culture media.
For the discovery of novel blood tumor markers and
biomarkers, omics approaches including proteomics and tran-
scriptomics are conducted either by direct analysis of blood
samples or application of profiling in tissue samples. There are
contradictory reports if whether the profiles of miRNA and
mRNAs in bloodstream are parallel with the tumor’s profile. The
signature of exosomal miRNAs reflects that of the originating
tumor cells in patients with lung adenocarcinoma [8] and breast
cancer [41]. On the other hand, Skog et al. have shown that
microarray analysis for mRNA derived from glioblastoma cells
and the corresponding exosomes revealed mRNAs exclusively
detected in microvesicles, speculating that mRNAs are localized to
a specific region of cytoplasm [3]. In addition, Tanaka et al. have
demonstrated that the level of miR-92a decreased in the blood
plasma of acute leukemia patients while its strong expression was
found in the tissue samples [24]. Our results on selective
enrichment of let-7 miRNA family in AZ-P7a cells-derived
exosomes fit with latter case. Unless target molecules are miRNAs
derived from circulating tumor cells, it suggests careful investiga-
tion are needed to use miRNA profiles in tissue samples for
detection in serum or plasma samples.
Since exosomes are produced in hematopoietic cells as well as
epithelial cells, circulating blood contains exosomes derived from
both type of cells. In general, to investigate exosomal profiles of
proteins, mRNAs, and miRNAs in serum and plasma, exosomes
derived from tumors with epithelial characteristics are separated
from those from hematopoietic cells [8,13]. This is performed
using affinity purification with antibodies against molecules such as
EpCAM that express on the surface of epithelial cells. Our findings
that there were similar levels of let-7 miRNA family between
exosomes and culture media from AZ-P7a cells suggest that these
miRNA levels may be measured without isolating exosomes from
clinical samples such as serum and plasma.
In conclusion, this study demonstrated that let-7 miRNA family
is rich in exosomes from a metastatic gastric cancer cell line, AZ-
P7a cells. Since let-7 miRNAs are involved in proliferation process
[31], their exosomal secretion may play an important role in
tumorigenesis and metastasis.
Materials and Methods
Cell culture
Human stomach cancer cell lines (AZ-521, MKN45, KATOIII,
and NUGC-3), human lung cancer cell lines (SBC-3, Lu-65, Lu-
135, and KNS-62), and human pancreatic cancer cells (Suit-2)
were purchased from Japanese Collection of Research Biore-
sources. Human stomach cancer cells (SNU-1), human lung
cancer cell lines (DMS-53, DMS114, NCI-H69, A549, NCI-
H1299, NCI-H1155, NCI-H520, NCI-H1560, SK-MES-1, and
HCC827), human mesothelioma cells (MSTO-H211), human
colorectal cancer cell lines (SW480, SW620, Colo205, LoVo, and
HCT116, human pancreatic cancer cell lines (BxPC-3, AsPC-1,
Table 1. Ranking of let-7 miRNA family in the intra- and extra-cellular fractions based on signal intensities from microarray data.
Cell line Sample Rank by signal intensity
let-7a let-7b let-7c let-7d let-7e let-7f let-7g let-7i miRNAs
AZ-P7a Cells 2 9 8 14 20 6 29 22 202
Ex 10 4 9 34 28 15 90 51 212
CM 30 13 22 71 83 46 147 63 209
AZ-521 Cells 3 4 5 13 17 6 22 18 171
Ex – 53 130 – – – – – 153
CM – 99 – – – – – 158 225
NCI-H69 Cells 1 2 6 25 27 4 44 23 261
E x – 4 1 ––– –– – 1 0 2
CM 36 16 24 86 91 55 – 69 131
SBC-3 Cells 1 31 56 83 17 7 115 – 132
E x – 3 8 ––– –– – 5 6
C M– –––– –– – 1 8 6
DMS53 Cells 2 8 20 16 – 9 29 10 85
E x – 2 5 ––– –– – 4 2
C M– –––– –– – 8 6
SW480 Cells 1 2 15 13 36 6 23 25 124
E x – 3 3 ––– –– – 4 7
C M– 7 2 ––– –– – 1 0 6
SW620 Cells 2 1 13 14 23 7 21 16 107
E x – –––– –– – 3 2
C M– –––– –– – 8 8
Ex=exosomes. CM=culture medium. miRNAs=the total number of miRNAs detected. A dash (-) indicates no detection.
doi:10.1371/journal.pone.0013247.t001
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prostate cancer cell lines (PC-3, SU145, and LNCaP), and human
breast cancer cell lines (T-47D, McF7, SK-BR-3, BT-474, and
MDA-MB-231) were purchased from American Type Culture
Collection. MKN28 (human stomach cancer cells) and PSN-1
(human pancreatic cancer cells) were purchased from Immuno-
Biological Laboratories and European Collection of Cell Culture,
respectively. Human stomach cancer cell lines, AZ-P7a [32,33]
and MKN45P [42] were gift from Drs. Yutaka Yonemura and
Yoshio Endo. In AZ-521 and AZ-P7a cells, no RT-PCR products
Figure 4. RT-PCR analyses of intra- and extra-cellular let-7 miRNA family. A, B. Levels of mature let-7 miRNA family including let-7a, let-7b,
let-7c, let-7d, let-7e, let-7f, let-7g, and let-7i in cells (shaded bars), exosomes (filled bars), and culture medium (open bars) from AZ-P7a cells (A) and
AZ-521 cells (B). Each miRNA level was analyzed using quantitative RT-PCR. The cycle threshold (Ct) value is presented as the mean 6 SD (n=4). C.
Levels of U6 snRNA in cells (shaded bars), exosomes (filled bars), and culture medium (open bars) from AZ-P7a and AZ-521 cells detected by
quantitative RT-PCR analysis. The cycle threshold (Ct) value is presented as the mean 6 SD (n=4). D. Relative amounts of let-7 miRNA family in cells
(shaded bars), exosomes (filled bars), and culture medium (open bars) from AZ-521 cells versus AZ-P7a cells. The dotted line and arrow represents the
levels of let-7 miRNA family in AZ-P7a cells, shown as 100%. The levels of U6 snRNA in each sample were used as an internal standard for
normalization amounts of let-7 miRNAs. Except let-7f and let-7g, the levels of let-7 miRNAs were reduced in the extracellular fractions. E. Relative
amounts of let-7a in cells (shaded bars) and exosomes (filled bars) from 7 cancer cell lines including AZ-P7a, AZ-521, NCI-H69, SBC-3, DMS53, SW480
and SW620 cells. The dotted line represents the levels in AZ-P7a cells, shown as 1. The levels of U6 snRNA in each sample were used for normalized
amounts of let-7a. The value of fold change is presented as the mean 6 SD (n=3) from samples independently prepared from cell culture. F. Relative
amounts of exosomal let-7a in 7 cancer cell lines. The dotted line represents the level in AZ-P7a cells, shown as 100%.
doi:10.1371/journal.pone.0013247.g004
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SV40, HBV, HCV, BKV, JCV, HHV7, HTLV1, HTLV2, HIV1,
HIV2, and ADV type 1 (data not shown), excluding infection by
these retroviruses in both the cell lines. Cells were maintained in
RPMI-1640 medium (Sigma-Aldrich) supplemented with 10%
heat-inactivated fetal bovine serum (Invitrogen), 100 U/ml
penicillin, and 0.1 mg/ml of streptomycin.
Production and isolation of exosomes
Adherent cells were seeded to 150 mm-dishes at appropriate
number of cells ranging from 3610
6 to 1610
7 cells per dish, while
floating cells were inoculated into 75 cm
2-flask at 2,2.5610
7 cells
per flask. Cells were cultured in complete RPMI-1640 medium of
25 ml and 50 ml for dishes and flasks, respectively, for 24 h at
37uC and 5% of CO2, washed twice with phosphate-buffered
saline (PBS), and incubated 48 h in phenol red-free RPMI-1640
medium (Sigma-Aldrich) containing 10% heat-inactivated fetal
bovine serum which was previously depleted contaminating
microvesicles by overnight centrifugation at 100,0006g. Exosomes
were isolated from the total cells ranging from 6610
7 to 3610
8
cells as previously described [29]. Briefly, culture medium was
collected and centrifuged at 8006g for 5 min and additional
2,0006g for 10 min to remove lifted cells. The supernatant was
subjected to filtration on a 0.1 mm pore polyethersulfone
membrane filter (Corning) to remove cell debris and large vesicles,
followed by concentration by a 100,000 Mw cut-off membrane
(CentriPlus-70, Millipore). The volume of supernatant was
reduced from approximately 250–500 ml to approximately
30 ml. The supernatant was then ultracentrifuged at 100,0006g
for 1 h at 4uC using 70Ti rotor (Beckman Coulter). The resulting
pellets were resuspended in 6 ml PBS and ultracentrifuged at
100,0006g for 1 h at 4uC using 100Ti rotor (Beckman Coulter).
Transmission electron microscopy
The pelleted exosomes were mixed with equal quantities of
freshly prepared 2% glutaraldehyde in PBS, incubated overnight
at 4uC, postfixed with 1% osmium tetroxide in PBS at 4uC for 2 h,
and dehydrated in a graded series of ethanol. Following
dehydration, the samples were transferred to propylene oxide
and embedded in epoxy resin Quetol 812 (Nisshin EM). Ultrathin
sections were cut with Ultracut UCT (LEICA), stained with uranyl
acetate and lead citrate, and observed with the JEM-1230 Electron
Microscope (JEOL). Immunoelectron microscopic analysis was
performed according to the method described by Xiao et al. [43]
with minor modifications. In brief, exosomes were mixed and
incubated with mouse anti-human CD63 monoclonal antibody
(catalog no. sc-51662, Santa Cruz) for 1 h at room temperature.
The sample was dropped onto the membrane surface of a copper
mesh (collodion/carbon coated 400 mesh, Nisshin EM) and
incubated for 1 h at room temperature. After wash with PBS,
immunogold conjugated goat anti-mouse IgG (catalog
no. EM.GMHL15, BBInternational) diluted at 1:20 was dropped
onto the membrane. The copper mesh was floated in the droplets
with its membrane surface faced down at room temperature for
30 min. After wash with PBS, uranyl acetate drops was put onto
the copper mesh surface and stained at room temperature for 30 s.
Exosomes with black colloidal gold particles on the capsular
membranes were marked as positive under the transmission
electron microscope.
Western blot analysis
Cells and exosomal fractions were washed, resuspended in a
lysis buffer [7.5 M urea (Sigma-Aldrich), 2.5 M thiourea (Sigma-
Aldrich), 12.5% glycerol (Wako), 50 mM Tris, 2.5% n-octyl-beta-
D-glucoside (Sigma-Aldrich), 6.25 mM Tris(2-carboxyethyl)pho-
sphine hydrochloride (Sigma-Aldrich), 1.25 mM protease inhibitor
(catalog no. P2714, Sigma-Aldrich)], and incubated for 1 h at 4uC
using the Rotator RT-50 (TAITEC). After centrifugation at
14,0006g for 60 min at 4uC, the supernatant was collected and
protein concentration was determined by the Bradford Protein
Assay Kit (Bio-Rad). A portion of proteins (10 mg) were denatured
by boiling in Laemmli sample buffer, run on 10% SDS-
polyacrylamide gels, and transferred to Immobilon-P PVDF
membranes (0.45 mm pore size, Millipore). The blots were blocked
for 1 h with 5% non-fat dry milk in Tris-buffered saline containing
Tween 20 (10 mM Tris–HCl, pH 7.5, 150 mM NaCl and 0.01%
Tween 20). After blocking the membranes were incubated with
each primary antibody or antiserum including rabbit anti-Tsg101
Figure 5. Models on difference in localization of let-7 miRNA family. Based on the results obtained by microarray and RT-PCR analyses, these
models were drawn. In comparison between AZ-P7a cells (left) and AZ-521cells (center), normalized by the amount of U6 snRNA (open triangles), the
amount of exosomal let-7a miRNA (filled triangles) in AZ-521 cells was approximately 3% of that in AZ-P7a cells while the intracellular amount in AZ-
521 cells was rather 1.4 times greater than that in AZ-P7a cells (Figure 4E). These models are applied to six of eight let-7 miRNA family tested,
including let-7a, let-7b, let-7c, let-7d, let-7e, and let-7i. In SW620 cells (right), the amount of let-7a was 3.5 times greater than that in AZ-P7a cells while
the amount of exosomal let-7a was 0.7 times less than in AZ-P7a cells (Figure 4E).
doi:10.1371/journal.pone.0013247.g005
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serum (catalog no. sc-49268, Santa Cruz), mouse monoclonal anti-
CD29/b1-integrin (catalog no. sc-610468, BD Biosciences), and
mouse monoclonal anti-Bip/Grp78 (catalog no. 610979, BD
Biosciences) at a dilution of 1:200 for 1 h at room temperature.
The blots were then incubated with the corresponding anti-IgG
secondary antibody conjugated with horseradish peroxidase
(Jackson Laboratories) at a dilution of 1:2,000 for 1 h at room
temperature. Specific proteins were visualized using the ECL
system (GE Healthcare) and the FUJIFILM Luminescent Image
Analyzer LAS3000 (Fuji Film). The protein molecular weight was
deduced using the Precision Plus Protein Standards (Bio-Rad
Laboratories).
RNA Isolation
For RNA isolation from culture medium, cells were seeded as
described above. 48 h after grown, culture medium was collected
and centrifuged at 8006g for 5 min and additional 2,0006g for
10 min. The supernatant was subjected to filtration on a 0.22 mm
pore polyethersulfone membrane filter (Corning), followed by
concentration with a 5,000 Mw cut-off membrane (Centricon
Plus-70, Millipore). The final volume of supernatant was
approximately 10–20 ml from the original volume of 250–
500 ml. The supernatant was mixed with equal volume of QIAzol
Lysis Reagent (Qiagen) and followed the procedure for RNA
isolation described below. Total RNA was isolated from cells,
exosomes, or culture media using the miRNeasy Mini Kit (Qiagen)
according to the manufacture’s instructions. To remove genomic
DNA, 40 mg of cellular total RNA were incubated with 40 units of
RQ1 RNase-Free DNase (Promega) at 37uC for 30 min in the
presence of 40 units of RNasin Plus RNase Inhibitor (Promega).
For total RNA from exosomes and culture media, all amounts of
crude products were treated in the same procedure except the use
of 5 U DNase. RNA was purified using the RNeasy MinElute
Cleanup Kit (Qiagen) according to the manufacturer’s instruc-
tions. The RNA samples were quantified with a NanoDrop
spectrophotometer (Thermo Fisher Scientific) and assessed using
the Agilent Small RNA Kit and the Agilent 2100 Bioanalyzer
(Agilent Technologies).
Microarray analysis
For miRNA profiling, 100 ng and 20 ng of cellular and
extracellular total RNAs, respectively, were fluorescence-labeled
using the miRNA Complete Labeling Reagent and Hyb Kit
(Agilent Technologies) according to manufacture’s protocol
(Agilent miRNA microarrays version 2.2). The comprehensive
miRNA analysis was performed using the Human miRNA
Microarray Kit (8615 K) Ver.3.0 (Agilent). Hybridization signals
were detected with the DNA Microarray Scanner (Agilent
Technologies). The scanned images were analyzed using the
Agilent Feature Extraction software and data analysis was
performed using the GeneSpring GX software (Agilent Technol-
ogies). The data discussed in this manuscript have been deposited
in NCBI’s Gene Expression Omnibus (GEO) and are accessible
through GEO Series accession number GSE21350: http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21350).
Reverse transcription (RT) and quantitative RT-PCR for
miRNA analysis
Quantitative miRNA levels were determined using real-time
RT-PCR with the Applied Biosystems 7900 HT Sequence
Detection System (Applied Biosystems), TaqManH Gene Expres-
sion Assay (Applied Biosystems) for human let-7a (assay ID
000377), let-7b (assay ID 002619), let-7c (assay ID 000379), let-7d
(assay ID 002283), let-7e (assay ID 002406), let-7f (assay ID
000382), let-7g (assay ID 002282), let-7i (assay ID 002221), and
U6 snRNA (assay ID 001973) as an endogenous control. Ten ng of
total RNA were subjected to reverse transcription with TaqManH
Universal PCR Master Mix No AmpErase (Applied Biosystems)
and the respective TaqManH reagents for target genes. RT-PCR
was carried out in a total volume of 20 ml reaction mixture
according to the manufacture’s protocol. Amplification was
carried out as follows: 95uC for 10 min, 40 cycles of 95uC for
15 s and 60uC for 60 s. Samples were analyzed in triplicate as
biological replicate or quadruplicate as technical replicate. The
miRNA levels were defined from the cycle threshold (Ct), the
comparative Ct method, and normalization by the level of U6
snRNA in each sample. Fold increases or decreases in each
miRNA level of cell lines tested were determined by reference to
the level of AZ-P7a cell line.
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